Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?

To: sam who wrote (2135)	3/26/1999 8:13:00 AM
From: Ed Ajootian	Read Replies (1) \| Respond to of 10280

IMO the stock sells off slightly from here, on huge volume. Could be some big intra-day gyrations but I believe Fidelity is not finished buying yet and will support the stock @ under the $110 mark. Hell, they've paid as much as $125 for this stock I believe. Short interest @ 3/15 actually _decreased a couple hundred thousand shares (to 3.7 mm). This is a clue that the $47 convertible bondholders have still yet to finish their shorting. Maybe some of the recent (and impending) volatility will induce them to push the panic button and short. Look for morning "buy" reiterations from the usual suspects. Maybe we'll even get some new analyst coverage now that this is a pharmaceutical company that is actually open for business and selling a product! In any event, much congrats to the SEPR crew!